These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

563 related articles for article (PubMed ID: 11084576)

  • 41. Insulin resistance in type II diabetes mellitus.
    Rizza R; Butler P
    Adv Second Messenger Phosphoprotein Res; 1990; 24():511-6. PubMed ID: 2169826
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Differential regulation of glucose transport and glucose transporter (GLUT-1) gene expression by vanadate, phorbol ester and okadaic acid in L6 skeletal muscle cells.
    Venkatesan N; Davidson MB
    Biochem Mol Biol Int; 1995 Nov; 37(4):773-83. PubMed ID: 8589651
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Acute exposure to rosiglitazone does not affect glucose transport in intact human skeletal muscle.
    Skrobuk P; Kuoppamaa H; Hiukka A; Koistinen HA
    Metabolism; 2010 Feb; 59(2):224-30. PubMed ID: 19765783
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Role of cortisol in the deterioration of glucose tolerance in Sudanese pregnant women.
    Ahmed SA; Shalayel MH
    East Afr Med J; 1999 Aug; 76(8):465-7. PubMed ID: 10520355
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Okadaic acid, vanadate, and phenylarsine oxide stimulate 2-deoxyglucose transport in insulin-resistant human skeletal muscle.
    Carey JO; Azevedo JL; Morris PG; Pories WJ; Dohm GL
    Diabetes; 1995 Jun; 44(6):682-8. PubMed ID: 7789633
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Vanadate treatment markedly increases glucose utilization in muscle of insulin-resistant fa/fa rats without modifying glucose transporter expression.
    Brichard SM; Assimacopoulos-Jeannet F; Jeanrenaud B
    Endocrinology; 1992 Jul; 131(1):311-7. PubMed ID: 1612011
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Mechanisms of inhibition of lipolysis by insulin, vanadate and peroxovanadate in rat adipocytes.
    Castan I; Wijkander J; Manganiello V; Degerman E
    Biochem J; 1999 Apr; 339 ( Pt 2)(Pt 2):281-9. PubMed ID: 10191258
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Characterization of signal transduction and glucose transport in skeletal muscle from type 2 diabetic patients.
    Krook A; Björnholm M; Galuska D; Jiang XJ; Fahlman R; Myers MG; Wallberg-Henriksson H; Zierath JR
    Diabetes; 2000 Feb; 49(2):284-92. PubMed ID: 10868945
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The upregulating effect of insulin and vanadate on cell surface insulin receptors in rat adipocytes is modulated by glucose and energy availability.
    Yu ZW; Eriksson JW
    Horm Metab Res; 2000 Aug; 32(8):310-5. PubMed ID: 10983626
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Microtiter well assays for protein tyrosine phosphatase activities directed against phosphorylated insulin receptor or insulin receptor substrate-1.
    Krützfeldt J; Grünweller A; Raasch W; Drenckhan M; Klein HH
    Anal Biochem; 1999 Jun; 271(1):97-9. PubMed ID: 10361012
    [No Abstract]   [Full Text] [Related]  

  • 51. The effect of mosapride (5HT-4 receptor agonist) on insulin sensitivity and GLUT4 translocation.
    Nam JS; Nam JY; Yoo JS; Cho M; Park JS; Ahn CW; Cha BS; Lee EJ; Lim SK; Kim KR; Lee HC
    Diabetes Res Clin Pract; 2010 Mar; 87(3):329-34. PubMed ID: 20060191
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Chronically increased S6K1 is associated with impaired IRS1 signaling in skeletal muscle of GDM women with impaired glucose tolerance postpartum.
    Barbour LA; McCurdy CE; Hernandez TL; Friedman JE
    J Clin Endocrinol Metab; 2011 May; 96(5):1431-41. PubMed ID: 21289241
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Insulin resistance, defective insulin receptor substrate 2-associated phosphatidylinositol-3' kinase activation, and impaired atypical protein kinase C (zeta/lambda) activation in myotubes from obese patients with impaired glucose tolerance.
    Vollenweider P; Ménard B; Nicod P
    Diabetes; 2002 Apr; 51(4):1052-9. PubMed ID: 11916925
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Impairments of insulin receptor function in insulin resistant states].
    Maegawa H
    Nihon Rinsho; 2000 Feb; 58(2):304-9. PubMed ID: 10707549
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Mechanism of pervanadate stimulation and potentiation of insulin-activated glucose transport in rat adipocytes: dissociation from vanadate effect.
    Shisheva A; Shechter Y
    Endocrinology; 1993 Oct; 133(4):1562-8. PubMed ID: 8404595
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Trying to understand gestational diabetes.
    Catalano PM
    Diabet Med; 2014 Mar; 31(3):273-81. PubMed ID: 24341419
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Alterations in skeletal muscle protein-tyrosine phosphatase activity and expression in insulin-resistant human obesity and diabetes.
    Ahmad F; Azevedo JL; Cortright R; Dohm GL; Goldstein BJ
    J Clin Invest; 1997 Jul; 100(2):449-58. PubMed ID: 9218523
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Vanadate stimulation of 2-deoxyglucose transport is not mediated by PI 3-kinase in human skeletal muscle.
    Cortright RN; Azevedo JL; Hickey MS; Tapscott EB; Dohm GL
    Biochim Biophys Acta; 1997 Oct; 1358(3):300-6. PubMed ID: 9366261
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Metformin increases insulin-stimulated glucose transport in insulin-resistant human skeletal muscle.
    Galuska D; Zierath J; Thörne A; Sonnenfeld T; Wallberg-Henriksson H
    Diabete Metab; 1991 May; 17(1 Pt 2):159-63. PubMed ID: 1936469
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Calorie restriction increases insulin-stimulated tyrosine phosphorylation of insulin receptor and insulin receptor substrate-1 in rat skeletal muscle.
    Dean DJ; Cartee GD
    Acta Physiol Scand; 2000 Jun; 169(2):133-9. PubMed ID: 10848643
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.